China Medical System Holdings Limited (OTCMKTS:CHSYF) Sees Significant Decline in Short Interest

China Medical System Holdings Limited (OTCMKTS:CHSYF) saw a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 20,000 shares, a decrease of 94.7% from the October 31st total of 374,900 shares. Based on an average daily trading volume, of 3,800 shares, the days-to-cover ratio is presently 5.3 days.

China Medical System Stock Performance

Shares of OTCMKTS:CHSYF remained flat at $0.93 during mid-day trading on Friday. China Medical System has a 1-year low of $0.93 and a 1-year high of $0.93. The business’s 50-day moving average is $0.93 and its 200 day moving average is $0.93.

China Medical System Company Profile

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.